Get my own profile
Public access
View all30 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Robin JonesROYAL MARSDEN AND INSTITUE OF CANCER RESEARCHVerified email at doctors.org.uk
- Venu G. PillarisettyProfessor of Surgery, University of WashingtonVerified email at uw.edu
- Hailing LuPrincipal Scientist, Immune Design CorporationVerified email at immunedesign.com
- Brian A Van TineWashington University in St LouisVerified email at wustl.edu
- Cassian YeeUT MD Anderson Cancer CenterVerified email at mdanderson.org
- Brett Schroeder, MDHeme-Onc Fellow at the National Cancer InstituteVerified email at nih.gov
- Yongwoo David SeoMD Anderson Cancer CenterVerified email at mdanderson.org
- Jan ter MeulenChief Scientific Officer at Obsidian TherapeuticsVerified email at mailer.uni-marburg.de
- Matthew B SprakerWashington University in St. LouisVerified email at wustl.edu
- Marissa VignaliSenior Manager, Research and Business Development, Adaptive BiotechnologiesVerified email at adaptivebiotech.com
- Shihong ZhangFred Hutchinson Cancer Research CenterVerified email at fredhutch.org
- Paul H HuangTeam Leader, Molecular & Systems Oncology, Institute of Cancer Research, London, UKVerified email at icr.ac.uk
- Teresa KimUniversity of Washington, Memorial Sloan-Kettering Cancer Center, Massachusetts General HospitalVerified email at alum.mit.edu
- Mihaela DrutaSarcoma Medical Oncologist, Moffitt Cancer CenterVerified email at moffitt.org
- Matthew NyflotUniversity of WashingtonVerified email at uw.edu
- Emanuela MarchesiIstituto Ortopedico RizzoliVerified email at ior.it
- Lilien VoongNorthwestern UniversityVerified email at u.northwestern.edu
- K. Scott BakerMember, Fred Hutchinson Cancer Research Center and Professor, University of Washington School of MedicineVerified email at fhcrc.org